Attentra Capsules
PDF Leaflet Revision Date: 9 July 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of ADHD in children, adolescents, and adults.
Dosage (summary)
Initial dose: 0.5 mg/kg for children <70 kg; 40 mg for those u226570 kg and adults. Maintenance: 1.2 mg/kg/day or 80 mg max.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
- Children under 6 years
Pregnancy & Breastfeeding
Not recommended during pregnancy; unknown if excreted in human milk.
Key Drug Interactions
- MAOIs
- CYP2D6 inhibitors
- Serotonergic medicines
- Anti-hypertensive medicines
Contraindications
- Hypersensitivity
- Narrow angle glaucoma
- Severe cardiovascular disorders
- Pheochromocytoma
- Liver impairment
Common side effects
- Decreased appetite
- Headache
- Nausea
- Fatigue
- Insomnia
Counselling Points
- Monitor for mood changes
- Avoid in pregnancy
- Use caution when driving
- Report any signs of liver injury
Serious warnings
- Suicidal ideation in children/adolescents
- Cardiovascular effects
- Potential for liver injury
Important Disclaimer
The Attentra Capsules professional information leaflet below is the property of Teva Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
